107 results on '"Zhang, Hui-Lai"'
Search Results
2. Quantum parametric amplifiation of phonon-mediated magnon-spin interaction
3. Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
4. Topological optomechanical amplifier with synthetic $\mathcal{PT}$-symmetry
5. Application of Development Seismic Key Technologies in Deep-Water Turbidite Sandstone Oilfields—A Case Study of The Block OML130 in West Africa
6. Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCD
7. Observation of $\mathcal{PT}$-symmetric quantum coherence in a single ion system
8. Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
9. Selective optomechanically-induced amplification with driven oscillators
10. A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria
11. Seismic-Driven Modeling Under the Constraints of Deep-Water Turbidite Channel Complexes Architecture Facies
12. A novel prognostic index for sporadic Burkitt lymphoma in adult patients: a real-word multicenter study
13. Topological optomechanical amplifier in synthetic PT $\mathcal{PT}$ -symmetry
14. Seismic-Driven Modeling Under the Constraints of Deep-Water Turbidite Channel Complexes Architecture Facies
15. Effects of the Host Plants of the Maize-Based Intercropping Systems on the Growth, Development and Preference of Fall Armyworm, Spodoptera frugiperda (Lepidoptera: Noctuidae)
16. Evaluation of the anti-breast cancer properties of Origanum majorana aqueous extract green-mediated nanoparticles
17. Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma
18. Quantum parametric amplification of phonon-mediated magnon-spin interaction
19. Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
20. Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T‐cell lymphoma
21. Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database
22. Glofitamab Monotherapy Demonstrates High Complete Response Rates and Manageable Safety in Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies
23. Phase I Study of the Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas
24. Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database.
25. Rituximab and bortezomib (RB): a new effective regimen for refractory or relapsed indolent lymphomas
26. Additional file 1 of A novel prognostic index for sporadic Burkitt lymphoma in adult patients: a real-word multicenter study
27. A Novel Prognostic Index for Sporadic Burkitt Lymphoma in Adult Patients: A Real-Word Multicenter Study
28. Biased immunoglobulin genes rearrangement in mantle cell lymphoma: Hints to identify the normal B-cell counterpart
29. Observation of PT -symmetric quantum coherence in a single-ion system
30. Capecitabine combined with weekly docetaxel in Chinese patients >65 years with anthracycline-resistant metastatic breast cancer
31. Bortezomib in combination with fludarabine and cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study
32. Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study.
33. Topological optomechanical amplifier in synthetic PT$\mathcal{PT}$ -symmetry
34. Selective and switchable optical amplification with mechanical driven oscillators
35. Co-targeting Aurora kinase A and Bcl-2 synergistically inhibits the viability in double-hit lymphoma cells
36. Necroptosis as a potential therapeutic target in multiple organ dysfunction syndrome
37. Preliminary Findings of a Phase Ib/II Trial Indicate Manageable Safety and Promising Efficacy for Mosunetuzumab in Combination with Lenalidomide (M+Len) in Previously Untreated (1L) Follicular Lymphoma (FL)
38. Rituximab and bortezomib (RB): a new effective regimen for refractory or relapsed indolent lymphomas
39. Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors
40. Nimotuzumab combined with gemcitabine and cisplatin as second‐line chemotherapy for advanced non‐small‐cell lung cancer
41. Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors
42. Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma.
43. [Clinical Significance of EBV-DNA Copy Number in EBV Positive Lymphoma Patients].
44. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
45. [Prognostic factors of nasal NK/T-cell lymphoma].
46. [Expression and prognostic value of regulatory T cells and M2 macrophages in diffuse large B-cell lymphoma tissues].
47. [Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].
48. [Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].
49. [Nimotuzumab in combination with chemotherapy in patients with advanced non-small cell lung cancer].
50. Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.